摘要
目的探究雾化吸入治疗COPD急性加重期的护理效果。方法选取我院在2016年1月—2017年12月接受治疗的COPD急性加重期患者60例作为研究对象,将其分为对照组和观察组,每组各30例。对照组采取常规护理,观察组患者采取综合护理,对比两组患者的临床疗效。结果观察组患者FEV1为(1.84±0.28)%,FEV1/FEV为(63.42±5.12)%,均高于对照组患者,差异均具有统计学意义(P<0.05);观察组患者治疗有效率为93.33%,高于对照组患者,差异具有统计学意义(P <0.05)。两组患者均未发生不良反应。结论在COPD患者的雾化吸入治疗期间采取综合护理可以有效促进患者临床疗效,无不良反应的发生。
Objective To investigate the effect of nebulized inhalation therapy on the acute exacerbation of COPD. Methods 60 cases of patients with acute exacerbation of COPD who were treated in our hospital from January 2016 to December 2017 were selected as the study objects and they were divided into control group and observation group, 30 cases in each group. The control group took routine care, and the observation group took comprehensive care. Clinical efcacy of the two groups of patients. Results The FEV1 in the observation group was （1.84±0.28）%, and the FEV1/FEV was （63.42±5.12）%, which was signifcantly higher than that in the control group, the difference was statistically significant （P〈0.05）. The effective rate in the observation group was 93.33%, which was signifcantly higher than that in the control group, the difference was statistically significant （P〈0.05）. No adverse reactions occurred in either group. Conclusion Taking comprehensive care during the inhalation therapy of COPD patients can effectively promote the clinical efficacy of patients, and no adverse reactions occur. It is worthy of clinical reference.
作者
季爱兰
JI Ailan(Department of Internal Medicine,The Eighth People＇s Hospital at Tongzhou District,Nantong Jiangsu 226361,China)
出处
《中国继续医学教育》
2018年第30期181-182,共2页
China Continuing Medical Education
